News & Analysis on Clinical Trial Services & Contract Research And Development
Gilde Healthcare Partners has bought a majority stake in specialist virology CRO Viroclinics Biosciences in a transaction prompted by growing global demand for virus research services and vaccines.
Catalent has been contracted to make supplies of an extended-release drug for Parkinson’s disease (PD) patients set to enter Phase III trials by developer Adamas Pharmaceuticals.
Patheon is the world’s largest pharmaceutical development services (PDS) provider and third largest contract manufacturer, according to a report released yesterday.
Reporting rules designed to prevent drug shortages are likely to be similar in Europe and the US according to the industry group that represents European generic drugmakers.
Excipient production at a BASF plant in Lugwigshafen, Germany has been deemed to meet standards set out under the excipact certification scheme.
INTERACTIVE MAP
The European Medicines Agency (EMA) has published for the first time details of manufacturers who have violated GMP as part of its transparency initiative.